Arcus Biosciences, Inc. ( RCUS) - Stock Earnings
RCUS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -98.0 million USD | 33.0 million USD |
| 2026Q1 | -128.0 million USD | 17.0 million USD |
| 2026Q2 | -91.0 million USD | 41.0 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
RCUS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -307.0 million USD | 117.0 million USD |
| 2024 | -283.0 million USD | 258.0 million USD |
| 2025 | -353.0 million USD | 247.0 million USD |
| 2026 Est. | — | — |
RCUS
Price: $29.48
52 week price:
Earnings Per Share: -3.94 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 965900
Market Capitalization: 3.6 billion